A Trial of SHR-A2102 for Treatment of Advanced Gynecological Malignancy
NCT06654440 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2024-12-10
Summary
The main objective of this study is to evaluate the effectiveness and safety of SHR-A2102 for participants with advanced gynaecological cancer.
Conditions
- Advanced Gynecological Malignancy
Interventions
- DRUG
-
SHR-A2102 for injection
SHR-A2102 for injection
Sponsors & Collaborators
-
Shanghai Hengrui Pharmaceutical Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-15
- Primary Completion
- 2025-08-31
- Completion
- 2026-10-31
Countries
- China
Study Locations
More Related Trials
-
A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 by Advanced Solid Tumor Subjects
NCT02721589 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study of SHR-2022 Injection in the Treatment of Patients With Advanced Malignant Tumors
NCT06131216 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Clinical Trial of HRS-4642 Plus SHR-A2102 in Patients With Advanced Solid Tumors
NCT06955390 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
A Clinical Study of SHR-4506 Injection in Patients With Malignant Tumors
NCT07068932 ·Status: RECRUITING ·Phase: PHASE1
-
SHR-4602 for Injection in Subjects With HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors
NCT06516926 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Phase II Study of SHR-1210 vs Placebo as Consolidation Chemotherapy After Radical Concurrent Chemoradiotherapy in Locally Advanced ESCC
NCT03817658 ·Status: UNKNOWN ·Phase: PHASE2
-
A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Esophageal Cancer
NCT06474468 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase II Study of SHR-4602 as Montherapy or in Combination With Other Anti-tumor Therapies in Advanced Solid Tumors
NCT06704828 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
SHR-1210 in Recurrent/Metastatic Nasopharyngeal Carcinoma Who Have Received Previous At Least Two Lines of Chemotherapy.
NCT03558191 ·Status: COMPLETED ·Phase: PHASE2
-
Single Arm Phase I Trail of Autologous Tumor Infiltrating Lymphocyte Injection (GT202) in the Treatment of Metastatic or Recurrent Gynecological Tumors
NCT05238818 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of SHR2150 (TLR7 Agonist) in Combination With Chemotherapy Plus PD-1 or CD47 Antibody in Subjects With Unresectable/ Metastatic Solid Tumors
NCT04588324 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study of GC201 TIL in Advanced Gynecologic Tumors (10hospital)
NCT05098171 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Exploratory Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Gynecologic Tumors
NCT05724732 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors
NCT06938880 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Clinical Study to Evaluate Safety, Tolerance, Pharmacokinetics and Efficacy of Sc610 Injection for Treating Advanced Urinary System Tumors
NCT05633589 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer
NCT06512051 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung Cancer
NCT04818333 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
A Clinical Study Evaluating the Safety and Efficacy of Anti-HER2-CAR-T Cells Injection in Patients With Solid Tumors
NCT06101082 ·Status: RECRUITING ·Phase: PHASE1
-
Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors
NCT06834542 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
A Study of BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies
NCT05803018 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of SHR-1210 in Combination With Chemotherapy in Advanced Esophageal Cancer
NCT03691090 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of ES014 in Subjects With Advanced Solid Tumors
NCT06543056 ·Status: RECRUITING ·Phase: PHASE2
-
A Clinical Study of SPH6516 Tablets in the Treatment of Advanced Solid Tumors.
NCT06266923 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid Tumors
NCT06238687 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
NCT07066657 ·Status: RECRUITING ·Phase: PHASE1